Aclaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research.

Medical - Diagnostics & Research
US, Wayne [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Aclaris Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Aclaris Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Aclaris Therapeutics, Inc..

End of ACRS's Analysis
CIK: 1557746 CUSIP: 00461U105 ISIN: US00461U1051 LEI: - UEI: -
Secondary Listings
ACRS has no secondary listings inside our databases.